Apoptosis‐based method for determining lot sizes in the filling of human‐induced pluripotent stem cells
暂无分享,去创建一个
Masahiro Kino-Oka | Ikki Horiguchi | Hirokazu Suigyama | Masaki Shiokaramatsu | Masashi Kagihiro | Kazuhiro Fukumori | M. Kino‐oka | I. Horiguchi | M. Kagihiro | K. Fukumori | Hirokazu Suigyama | Masaki Shiokaramatsu
[1] Ruth E. Chambers. Topics , 1973, Seminars in Perinatology.
[2] Renzo Akkerman,et al. Classifying and modeling setups and cleanings in lot sizing and scheduling , 2017, Eur. J. Oper. Res..
[3] Yeu-Shiang Huang,et al. Determination of optimal lot size and production rate for multi-production channels with limited capacity , 2015, Int. J. Syst. Sci..
[4] Rongbing Huang,et al. Integrated pricing and lot-sizing decision in a two-echelon supply chain with a finite production rate , 2015 .
[5] Hirokazu Sugiyama,et al. Economic Model for Lot-Size Determination in Pharmaceutical Injectable Manufacturing , 2019, Journal of Pharmaceutical Innovation.
[6] G. Bitran,et al. Computational Complexity of the Capacitated Lot Size Problem , 1982 .
[7] Masahiro Kino-oka,et al. A distribution-based approach for determining lot sizes in the filling of human-induced pluripotent stem cells , 2019, Regenerative therapy.
[8] M. Odell,et al. The hormone-releasing intrauterine device has benefits over hysterectomy for many women. Press release. , 2009, Acta obstetricia et gynecologica Scandinavica.
[9] Robert M. Vogel,et al. Mitochondrial origins of fractional control in regulated cell death , 2019, Nature Communications.
[10] Jacob Cohen,et al. A power primer. , 1992, Psychological bulletin.
[11] M. Kino‐oka,et al. Kinetic analysis of cell decay during the filling process: Application to lot size determination in manufacturing systems for human induced pluripotent and mesenchymal stem cells , 2018 .
[12] K. Machida,et al. Characterization of in vivo tumorigenicity tests using severe immunodeficient NOD/Shi-scid IL2Rγnull mice for detection of tumorigenic cellular impurities in human cell-processed therapeutic products , 2015, Regenerative therapy.
[13] P. Lachenbruch. Statistical Power Analysis for the Behavioral Sciences (2nd ed.) , 1989 .
[14] Tak Yee Aw,et al. Reactive oxygen species, cellular redox systems, and apoptosis. , 2010, Free radical biology & medicine.
[16] Jacob Cohen. Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.
[17] Dieter Eibl,et al. Single-Use Technology in Biopharmaceutical Manufacture , 2011 .
[18] M. Kino‐oka,et al. Suppression of time-dependent decay by controlling the redox balance of human induced pluripotent stem cells suspended in a cryopreservation solution , 2020 .
[19] Hirokazu Sugiyama,et al. Slow freezing process design for human induced pluripotent stem cells by modeling intracontainer variation , 2020, Comput. Chem. Eng..
[20] F. Rombouts,et al. Modeling of the Bacterial Growth Curve , 1990, Applied and environmental microbiology.
[21] Hemanthram Varadaraju,et al. Downstream Technology Landscape for Large-Scale Therapeutic Cell Processing , 2013 .
[22] A. Hubel,et al. Algorithm‐driven optimization of cryopreservation protocols for transfusion model cell types including Jurkat cells and mesenchymal stem cells , 2017, Journal of tissue engineering and regenerative medicine.
[23] Joana Galvao,et al. Unexpected low‐dose toxicity of the universal solvent DMSO , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[24] Elisabet Capón-García,et al. Rigorous approach to scheduling of sterile drug product manufacturing , 2016, Comput. Chem. Eng..
[25] Masahiko Hirao,et al. Erratum to: Decision-Support Method for the Choice Between Single-Use and Multi-Use Technologies in Sterile Drug Product Manufacturing , 2017, Journal of Pharmaceutical Innovation.
[26] F. Gòdia,et al. A general artificial neural network for the modelization of culture kinetics of different CHO strains , 2001, Cytotechnology.